CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 60 year old female.  Initial information was processed with the additional information received on 25-MAY-2022. The patient's weight was 55 kilograms, and height was 170 centimeters.  The patient's pre-existing medical conditions included: The patient had no other conditions. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, start therapy date was not reported for prophylactic vaccination.  The batch number was not reported and has been requested. She had the Johnson and Johnson vaccine which was a farce (Dose number in series 1).  The patient received additional non-company suspect vaccine included: Moderna (elasomeran, Dose number in series 2) (form of admin, route of admin, and batch number were not reported) dose was not reported, administered on an unspecified date in OCT-2021 for prophylactic vaccination.  Concomitant medications included trazodone for sleep, and rosuvastatin calcium.  On an unspecified date, the patient tested positive on PCR test for COVID (confirmed covid-19 infection (dose number in series 2) and confirmed clinical vaccination failure (dose number in series 1)). The patient took Paxlovid (nirmatrelvir and ritonavir) from 05-MAY-2022 to 09-MAY-2022 (5 days), tablet by mouth, with unspecified dose, two tablets a day, one tablet in the morning and one tablet at night, total of 10 tablets as she was tested positive on PCR test for COVID. There were a couple of medications she was not supposed to take with Paxlovid, one was Trazodone and the other Crestor 5 mg (rosuvastatin calcium). She did not take Crestor 5 mg for 5 days during Paxlovid treatment, but she did take her normal dose of Trazodone because she needed to sleep. She was tested negative two days later on 11-MAY-2022 and felt great. On 13-MAY-2022, she felt sick, started to feel bad and took a test and it was positive. She took two different brands at home tests on 14-MAY-2022 and tested positive on both tests. The patient took another home test on 16-MAY-2022 and this one also came back positive. Her symptoms were worse. She saw another doctor since her doctor was not available. She was sitting in the hospital getting monoclonal antibodies as on report time, which was called Bebtelovimab 175 mg. She was not admitted to hospital, she was only there for the monoclonal antibody treatment (dose number in series 2).  The action taken with covid-19 vaccine ad26.cov2.s, and elasomeran was not applicable. The outcome of the confirmed covid-19 infection and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000232825.; Sender's Comments: V0: 20220550857-covid-19 vaccine ad26.cov2.s-Confirmed clinical vaccination failure. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related. 20220550857-covid-19 vaccine ad26.cov2.s-Confirmed COVID-19 infection. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.